ArticleBMC surgery2026
Delayed post-pancreaticoduodenectomy hemorrhage: is endovascular treatment a strategic necessity?
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLate post-pancreaticoduodenectomy hemorrhage (PPH) is a rare but potentially fatal complication associated with high morbidity and mortality. Early recognition and prompt intervention are critical for improving patient outcomes. This study aimed to evaluate the clinical features, treatment modalities, and outcomes of late-onset PPH cases managed in our institution. MATERIALS AND
methodsBetween January 2016 and January 2025, a total of 220 patients underwent pancreaticoduodenectomy (PD) at the Department of General Surgery, XXX University Faculty of Medicine. Patients who developed late arterial hemorrhage, defined by the International Study Group of Pancreatic Surgery (ISGPS) as occurring more than 24 h after the index operation, were included. Demographic data, histopathological diagnoses, timing and source of bleeding, radiological and angiographic findings, treatment modalities, rebleeding events, morbidity, and mortality rates were analyzed. In patients undergoing endovascular treatment (EVT), technical success and complications were recorded.
resultsLate PPH occurred in 5.9% (13/220) of patients, with a mean onset of 10.3 days postoperatively. The most frequent bleeding source was the gastroduodenal artery (61.5%), and 61.5% of patients had an anastomotic leak. Sentinel bleeding was present in 76.9% of cases. EVT was performed in eight patients, achieving technical success in 75% after the first attempt and 100% after repeat procedures; rebleeding occurred in 25%. Surgical intervention was performed in five patients, with remnant pancreatectomy required in 60% of cases. Mortality was 60% in the surgical group and 25% in the EVT group. No cases of hepatic ischemia or abscess were observed following hepatic artery embolization.
conclusionEndovascular therapy appears to be a feasible first-line approach for the management of late PPH and may achieve high technical success. Surgical intervention should be reserved for selected cases in which EVT is unavailable or unsuccessful.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.